These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 25333496)
1. Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer. Rossi M; Buratto M; Tagliati F; Rossi R; Lupo S; Trasforini G; Lanza G; Franceschetti P; Bruni S; Degli Uberti E; Zatelli MC Thyroid; 2015 Feb; 25(2):221-8. PubMed ID: 25333496 [TBL] [Abstract][Full Text] [Related]
2. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338 [TBL] [Abstract][Full Text] [Related]
3. Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. Sadow PM; Heinrich MC; Corless CL; Fletcher JA; Nosé V Endocr Pathol; 2010 Jun; 21(2):73-9. PubMed ID: 20012784 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens. Ko YS; Hwang TS; Kim JY; Choi YL; Lee SE; Han HS; Kim WS; Kim SK; Park KS Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417935 [TBL] [Abstract][Full Text] [Related]
5. Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia. Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Pupic G; Zivkovic O; Markovic I; Djurisic I; Buta M; Dimitrijevic B; Rogounovitch T; Mitsutake N; Mine M; Shibata Y; Nakashima M; Yamashita S Endocr J; 2011; 58(5):381-93. PubMed ID: 21498916 [TBL] [Abstract][Full Text] [Related]
6. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937 [TBL] [Abstract][Full Text] [Related]
7. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany. Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986 [TBL] [Abstract][Full Text] [Related]
9. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Sapio MR; Posca D; Raggioli A; Guerra A; Marotta V; Deandrea M; Motta M; Limone PP; Troncone G; Caleo A; Rossi G; Fenzi G; Vitale M Clin Endocrinol (Oxf); 2007 May; 66(5):678-83. PubMed ID: 17381488 [TBL] [Abstract][Full Text] [Related]
10. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487 [TBL] [Abstract][Full Text] [Related]
11. Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. Musholt TJ; Fottner C; Weber MM; Eichhorn W; Pohlenz J; Musholt PB; Springer E; Schad A World J Surg; 2010 Nov; 34(11):2595-603. PubMed ID: 20652698 [TBL] [Abstract][Full Text] [Related]
12. Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer. Ming J; Liu Z; Zeng W; Maimaiti Y; Guo Y; Nie X; Chen C; Zhao X; Shi L; Liu C; Huang T Int J Clin Exp Pathol; 2015; 8(11):15155-62. PubMed ID: 26823860 [TBL] [Abstract][Full Text] [Related]
13. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population. Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330 [TBL] [Abstract][Full Text] [Related]
14. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. Guerra A; Zeppa P; Bifulco M; Vitale M Thyroid; 2014 Feb; 24(2):254-9. PubMed ID: 23806056 [TBL] [Abstract][Full Text] [Related]
15. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland. Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135 [TBL] [Abstract][Full Text] [Related]
16. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433 [TBL] [Abstract][Full Text] [Related]
17. Multiplex PCR approach to simultaneously identify several mutations in fine needle cytology thyroid samples. Vuttariello E; Borra M; Mauriello E; Calise C; D'Andrea B; Capiluongo A; Fulciniti F; Cipolletta A; Monaco M; Pezzullo L; Chiappetta G Oncotarget; 2017 Jul; 8(30):49351-49358. PubMed ID: 28537891 [TBL] [Abstract][Full Text] [Related]
18. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules. Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402 [TBL] [Abstract][Full Text] [Related]
19. Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients. Fulciniti F; Cipolletta Campanile A; Malzone MG; Chiofalo MG; Capiluongo A; Monaco M; Di Maio N; Sandomenico F; Botti G; Chiappetta G; Vuttariello E; Pezzullo L Clin Endocrinol (Oxf); 2019 Dec; 91(6):851-859. PubMed ID: 31483883 [TBL] [Abstract][Full Text] [Related]